8

Live / Registered — Registered (as of 15 Apr 2025)

What this means for you

Registered since 15 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98350278
Registration number
7763735
Mark type
Design + words
Filed
10 Jan 2024
Published for opposition
13 Aug 2024
Registered
15 Apr 2025
Attorney of record
Jonathan M. Rixen

Goods and services

  • Class 001 — Chemicals: Active pharmaceutical ingredients (APIs), namely, oligonucleotide APIs for use in the manufacture of pharmaceuticals for treating tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; active chemical ingredients for use in the manufacture of pharmaceuticals for treating tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia

Owner

Prosecution history

  • 15 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 15 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
  • 24 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 24 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 21 Mar 2025 — STATEMENT OF USE PROCESSING COMPLETE
  • 16 Jan 2025 — USE AMENDMENT FILED
  • 21 Mar 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 14 Jan 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 14 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 14 Jan 2025 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
  • 14 Jan 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 14 Jan 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 16 Jan 2025 — TEAS STATEMENT OF USE RECEIVED
  • 08 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 13 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

View this trademark record on Marksy